东星医疗
(301290)
| 流通市值：22.05亿 | | | 总市值：32.41亿 |
| 流通股本：6816.09万 | | | 总股本：1.00亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 90,470,397.6 | 387,491,879.48 | 283,737,516.84 | 183,292,306.61 |
| 营业收入 | 90,470,397.6 | 387,491,879.48 | 283,737,516.84 | 183,292,306.61 |
| 二、营业总成本 | 76,752,373.59 | 337,268,334.44 | 245,520,282.82 | 163,130,797.38 |
| 营业成本 | 45,029,457.2 | 199,213,228.46 | 147,468,580.15 | 97,573,435.14 |
| 税金及附加 | 1,411,768.27 | 5,518,674.05 | 4,043,497.65 | 2,498,396.89 |
| 销售费用 | 9,625,118.58 | 46,367,017.81 | 33,791,434.11 | 22,308,254.63 |
| 管理费用 | 15,453,279.19 | 63,941,156.18 | 46,609,223.76 | 32,249,472.08 |
| 研发费用 | 4,574,302.29 | 20,971,465.7 | 13,107,931.23 | 8,419,735.46 |
| 财务费用 | 658,448.06 | 1,256,792.24 | 499,615.92 | 81,503.18 |
| 其中:利息费用 | 412,028.4 | 1,274,131.63 | 862,315.13 | 518,203.73 |
| 其中:利息收入 | 39,465.75 | 671,583.96 | 809,921.85 | 777,545.4 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 792,825.2 | 3,009,016.45 | 807,275.54 | 2,662,563.62 |
| 加:投资收益 | 6,619,692.18 | 25,124,609.35 | 18,893,562.47 | 11,144,971.24 |
| 资产处置收益 | - | -34,272.58 | -18,726.95 | -12,070.87 |
| 资产减值损失(新) | -45,484.26 | -107,992,256.77 | -103,633,640.88 | 19,648.12 |
| 信用减值损失(新) | -581,411.19 | 631,861.63 | 1,278,685.66 | 1,293,770.04 |
| 其他收益 | 975,636.4 | 2,598,224.25 | 1,921,865.18 | 1,208,559.61 |
| 四、营业利润 | 21,479,282.34 | -26,439,272.63 | -42,533,744.96 | 36,478,950.99 |
| 加:营业外收入 | 3,077.96 | 93,661.11 | 92,271.74 | 76,262.55 |
| 减:营业外支出 | 197,986.05 | 1,231,591.03 | 649,699.81 | 646,794.05 |
| 五、利润总额 | 21,284,374.25 | -27,577,202.55 | -43,091,173.03 | 35,908,419.49 |
| 减:所得税费用 | 3,767,621.29 | 12,318,597.47 | 10,430,618.76 | 6,254,071.55 |
| 六、净利润 | 17,516,752.96 | -39,895,800.02 | -53,521,791.79 | 29,654,347.94 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 17,516,752.96 | -39,895,800.02 | -53,521,791.79 | 29,654,347.94 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 17,916,413.08 | -37,940,258.51 | -53,201,637.49 | 30,292,870.97 |
| 少数股东损益 | -399,660.12 | -1,955,541.51 | -320,154.3 | -638,523.03 |
| 扣除非经常损益后的净利润 | 11,809,691.95 | -60,130,347.44 | -69,618,643.68 | 19,036,505.31 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.18 | -0.38 | -0.53 | 0.3 |
| (二)稀释每股收益 | 0.18 | -0.38 | -0.53 | 0.3 |
| 九、综合收益总额 | 17,516,752.96 | -39,895,800.02 | -53,521,791.79 | 29,654,347.94 |
| 归属于母公司股东的综合收益总额 | 17,916,413.08 | -37,940,258.51 | -53,201,637.49 | 30,292,870.97 |
| 归属于少数股东的综合收益总额 | -399,660.12 | -1,955,541.51 | -320,154.3 | -638,523.03 |
| 公告日期 | 2026-04-21 | 2026-04-21 | 2025-10-29 | 2025-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |